A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.

A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.

Vanderbilt researchers show that two factors promote the repair of myelin, the nerve cell covering that deteriorates in diseases such as multiple sclerosis.

Vanderbilt investigators have discovered details about the mechanism of an important DNA repair protein that maintains genome stability.

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

Adherence to medication was the only self-care activity independently associated with glycemic control in a low-income population.